Answers are grounded in this paper and cite their sources.
Global studies of respiratory diseases, particularly asthma, noted a decrease in exacerbations of up to 63%1,2 during the COVID-19 pandemic. This unexpected reduction provided crucial respite in hospital admissions, helping to meet the increased demand on healthcare resources posed by the pandemic. It is hypothesised that the decrease in asthma exacerbations (Fig. 1: data from the Office for National Statistics, UK) was due to a decrease in the circulating common respiratory viruses, further supported by patient shielding.
No takes yet. Share an insight, caveat, or question.
Vancheeswaran et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: